These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4008971)

  • 21. [Intravesical instillations of BCG and bladder carcinoma in situ].
    Haab F; Dauge MC; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):988-94; discussion 992-3. PubMed ID: 8305942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma in situ of the urinary tract.
    Utz DC; Farrow GM
    Urol Clin North Am; 1984 Nov; 11(4):735-40. PubMed ID: 6390917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urinary tumor marker for urothelial cancer].
    Ohtani M; Iwasaki A; Shiraiwa H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytology in the assessment of patients with painless gross haematuria.
    Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
    BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micropapillary urothelial carcinoma in a renal transplant recipient: a case report on urine cytomorphology emphasizing differentiation from high-grade urothelial carcinoma.
    Seo KJ; Shin OR; Lee JY; Choi YJ
    Cytopathology; 2015 Aug; 26(4):264-6. PubMed ID: 25123813
    [No Abstract]   [Full Text] [Related]  

  • 27. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of urinary cytology in the diagnosis and management of urinary tract malignancies.
    Gaston KE; Pruthi RS
    Urology; 2004 Jun; 63(6):1009-16. PubMed ID: 15183936
    [No Abstract]   [Full Text] [Related]  

  • 31. [The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis].
    Saito J; Kato T; Kakuta Y; Tanaka M; Yazawa K; Hosomi M; Ito K
    Hinyokika Kiyo; 2006 Jul; 52(7):573-5. PubMed ID: 16910594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of urinary cytology in urological diagnosis. Report after ten years (author's transl)].
    Jocham D; Göttinger H; Schmiedt E
    Urologe A; 1982 Mar; 21(2):79-83. PubMed ID: 7200668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The occult urothelial cancer.
    Ragonese M; Racioppi M; D'Agostino D; Di Gianfrancesco L; Lenci N; Bientinesi R; Palermo G; Sacco E; Pinto F; Bassi PF
    Urologia; 2016 May; 83(2):55-60. PubMed ID: 26481721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
    Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine cytology discrepancies: frequency, causes, and outcomes.
    Raab SS; Grzybicki DM; Vrbin CM; Geisinger KR
    Am J Clin Pathol; 2007 Jun; 127(6):946-53. PubMed ID: 17509992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of patients with carcinoma in situ of the bladder.
    Koss LG
    Pathol Annu; 1982; 17 Pt 2():353-9. PubMed ID: 7182757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.